FOUNDATION FIGHTING BLINDNESS RETINAL DEGENERATION FUND sold 31.0% of their position (1.70M shares) of OPUS GENETICS, INC. on the open market
Open‑market sale worth $7.39M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/20/2026ACC: 0002042266-26-000001
→
DirectorOther
Since Oct 2024
-1.70M
Net shares
Net seller
$7.39M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.70M disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.70M
Price / share
$4.35
Trade value
$7.39M
% of position
31.0%
5/18/2026
5.49M→3.79M
Total
Net shares
−1.70M
Net value
-$7.39M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/18/2026 | S · Sale | −1.70M | $4.35 | $7.39M | 31.0% | 5.49M | 3.79M |
| Total | −1.70M | -$7.39M | ||||||
Derivative Transactions0
No derivative transactions reported